Abstract
Oncological pathology in type 2 diabetes patients and its effects on the effectiveness of the treatment of diabetes
Highlights
A combination of type 2 diabetes and cancer as the most common noncommunicable diseases, leading to significant social and economic consequences for individuals, their families and, in general, national health systems, requires scientific research, in particular the study of the mechanisms underlying such a combination, and the factors that lead to it.Goal
The incidence of oncologic pathology in patients with type 2 diabetes has significant differences depending on the patient's sex, territory and place of residence, duration of diabetes, body mass index (BMI), HbA1c, macrovascular complications and medication tactics
The incidence of oncological pathology in patients with type 2 diabetes depending on macrovascular complications, n (%)
Summary
The study found that the incidence of cancer (table 1) in patients with MI and stroke (7.12% and 10.1%, respectively) exceeds rates in patients without. The incidence of oncological pathology in patients with type 2 diabetes depending on macrovascular complications, n (%). The incidence of cancer in women (8.81% among all women studied) the same in patients without macrovascular complications, on tablet drug therapy and combination therapy, higher in patients with MI and stroke, Western and Southern Ukraine, duration of diabetes mellitus type [11-15] years, BMI 35-39.9 kg/m2 and over 40 kg/m2, HbA1c up to 6.0% and 8.1-9.0%, but less in patients with UDF, Eastern Ukraine and the territories of military conflict, duration of type 2 diabetes over 20 years, rural area, BMI 18.5-24.9 kg/m2, HbA1c 8.1-9.0% and more than 10.0% on insulin therapy. The average HbA1c in the whole group Average HbA1c in patients with cancer with MI (n =267)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
